sellWeak cluster of 3
Michael F Marino III sold $28k of OPTN
Chief Legal Officer & Corp Sec at OptiNose, Inc.. 15,059 shares at an average of $1.88, traded Mar 18, 2024, filed Mar 19, 2024.
Warning score
35Value
$28k
15,059 shares
Holdings after
602,268
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +5Trade size$28k at market
- 0Share of holdings soldSold 2.4% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001494650-24-000036, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 15, 2024 | AGrant or award Common Stock | +3,816 | $0.00 | $0 | 617,327 | Mar 19, 2024 |
| Mar 18, 2024 | SOpen-market sale Common Stock | -15,059 | $1.88 | $28k | 602,268 | Mar 19, 2024 |
Related signals
Other insiders at OptiNose, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | OptiNose, Inc. | Ramy A Mahmoud Chief Executive Officer | $2,030 4,614 shares | -0% | |
| 23Weak | OptiNose, Inc. | Michael F Marino III Chief Legal Officer & Corp Sec | $1,342 3,050 shares | -1% | |
| 30Weak | OptiNose, Inc. | Anthony J Krick Chief Accounting Officer | $4,409 2,345 shares | -2% | |
| 46Moderate | OptiNose, Inc. | Ramy A Mahmoud Chief Executive Officer | $36k 19,198 shares | -1% | |
| 33Weak | OPTNsell OptiNose, Inc. | Ramy A Mahmoud Chief Executive Officer | $69k 52,875 shares | -9% | |
| 33Weak | OptiNose, Inc. | Ramy A Mahmoud Chief Executive Officer | $13k 11,114 shares | -2% | |
| 23Weak | OptiNose, Inc. | Michael F Marino III Chief Legal Officer & Corp Sec | $5,756 5,005 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.